Market Currents
AbbVie (ABBV -0.4%) slips a bit today on a tepid initiation at UBS with a Neutral rating and a...
-
Friday, January 11, 1:05 PM ETAbbVie (ABBV -0.4%) slips a bit today on a tepid initiation at UBS with a Neutral rating and a lackluster price target of $36 on the stock. The firm cites a lack of carity in its pipeline, competition for Humira from oral therapies and generics, as well as earnings being pressured by its lipid and HIV franchises going generic.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
